The higher NIC dose resulted in even more significant reductions in TNF-α and iNOS protein expression and NF-κB-p65 gene expression, with reductions of approximately 50%, 65%, and 50%, respectively, relative to the TAA-induced liver fibrosis group. The gene discussed is NOS2; the disease is Hepatic fibrosis.